Results 171 to 180 of about 20,142 (302)
Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
Yahya Almodallal +4 more
wiley +1 more source
Assessment of genetically modified maize DP202216 × NK603 × DAS‐40278‐9 (application GMFF‐2022‐6232)
Abstract Genetically modified maize DP202216 × NK603 × DAS 40278‐9 was developed by crossing to combine three single events: DP202216, NK603 and DAS‐40278‐9. The three‐event stack maize expresses PAT, CP4 EPSPS, CP4 EPSPS L124P, AAD‐1 and the maize endogenous protein with altered expression (EPAE) ZMM28 to confer herbicide tolerance and to provide the ...
EFSA Panel on Genetically Modified Organisms (GMO) +29 more
wiley +1 more source
EFFECT OF PYRIDOXINE DEFICIENCY ON NUCLEIC ACID METABOLISM IN THE RAT [PDF]
AC TRAKATELLIS, AE Axelrod
openalex +1 more source
Cystathionine β‐synthase deficiency in the
Viktor Kožich +10 more
openalex +1 more source
Abstract Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of clinoptilolite of volcanic origin as a technological feed additive for all terrestrial animal species.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) +25 more
wiley +1 more source
Abstract Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of perlite as a technological feed additive for all terrestrial animal species.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) +25 more
wiley +1 more source
The relation of liver kynureninase to tryptophan metabolism in pyridoxine deficiency
W. Eugene Knox
openalex +2 more sources
Profiling Inhibitor Scaffolds for the Cancer Target Jumonji‐C Domain‐Containing Protein 6
High‐throughput mass spectrometry assays identify scaffolds for the development of inhibitors of the anticancer target Jumonji‐C domain‐containing protein 6 (JMJD6). Molecular docking studies suggest strategies for structure‐guided inhibitor optimization.
Thomas P. Corner +5 more
wiley +1 more source
Effects of Pyridoxine Deficiency on the Metabolism of N-Nitrosodimethylamine in the Rat.
Auratai Aramphongphan +5 more
openalex +2 more sources
Potential of AON therapy targeting AASS: A promising molecular therapy for pyridoxine-dependent epilepsy. [PDF]
Salih MA.
europepmc +1 more source

